Journal of Nature and Science of Medicine · مجلد 8 (4) · 260-265
Abstract Introduction: External accreditation is critical to the viability and sustainability of educational programs in medical schools. Before 2004, medical programs in Saudi Arabia required no accreditation and relied on institutional and internal faculty-led program-review processes. However, with the increasing number of colleges, the Ministry of Education recognized the importance of establishing an independent national body to serve as the highest authority in accreditation and assessment for higher education institutions and programs. Methods: This study used a qualitative research design. We conducted focus group sessions using the focus group protocol, where five focus groups, each of 1-h duration, were conducted at the College of Medicine, King Saud University, between February and March 2020. Participants were recruited using convenience sampling from various stakeholders of the NCAAA accreditation project. Two researchers (NZ and SA) facilitated the focus group sessions. Results: Accreditation can be divided into two processes: Technical and emotional. We identified five subthemes in the technical aspect: Creating a roadmap, establishing a task force, conducting workshops, data collection, and communicating with the accrediting body. However, in the emotional process, accreditation was perceived as a difficulty and part of the change that triggered resistance. Conclusion: Undergoing accreditation is perceived as a lengthy and time-sensitive process that focuses on creating task forces, developing engagement strategies, planning data collection and documentation, and communicating efficiently with the accrediting body. The anticipation of positive and negative internal and external emotions as part of a change process with a clear plan to adapt and accommodate such a reaction is essential.
medical school accreditationexternal accreditationaccreditation processstakeholder perspectives
strategic objectives. The MOH is reforming the way healthcare will be managed in the future and is in the process of transferring healthcare service delivery responsibilities to clusters with ratified boards, while also moving the MOH from a provision of service model to a regulatory one. Several early pathfinding clusters were initiated in the eastern central and western regions. To ensure northern and southern regions were not left behind, the early innovation, while awaiting cluster nomination status, the northern and southern business units of Health Holding Company implemented the accelerated transformation programme (ATP). The ATP's remit was to develop capabilities and stimulate local engagement and ownership in the healthcare transformation process. This paper summarises the process of healthcare transformation undertaken in the northern and southern regions of KSA to date. It reviews the success in engaging with local healthcare professional communities in a standardised way and the learning from previous clusters, and elaborates on emerging implementation issues and how we may overcome them and introduce the lessons learnt from this journey.
healthcare transformationMinistry of Healthhealth care deliverylocal ownership
Saudi Pharmaceutical Journal · مجلد 31 (7) · 1360-1366
Objectives: This study was designed to assess the disproportionality analyses of adverse drug reactions (ADRs) related to hydroxychloroquine and remdesivir and how ADR reporting fluctuated during the COVID-19 pandemic. Methods: A retrospective observational study was conducted utilizing the Food and Drug Administration's Adverse Event Reporting System (FAERS) data between 2019 and 2021. The study was conducted in two phases. In the first phase, all reports associated with the drugs of interest were evaluated to assess all related adverse drug reactions. In the second phase, specific outcomes of interest (i.e., QT prolongation and renal and hepatic events) were determined to study their association with the drugs of interest. A descriptive analysis was conducted for all adverse reactions related to the drugs being studied. In addition, disproportionality analyses were conducted to compute the reporting odds ratio, the proportional reporting ratio, the information component, and the empirical Bayes geometric mean. All analyses were conducted using RStudio. Results: A total of 9,443 ADR reports related to hydroxychloroquine; 6,160 (71.49) patients were female, and higher percentage of patients of both sexes were over the age of 65 years. QT prolongation (1.48%), pain (1.38%), and arthralgia (1.25%) were most frequently reported ADRs during the COVID-19 pandemic. The association of QT prolongation with use of hydroxychloroquine was statistically significant (ROR 47.28 [95% CI 35.95-62.18]; PRR 42.41 [95% CI 32.25-55.78]; EBGM 16.08; IC 4.95) compared with fluoroquinolone. The outcome was serious medical events in 48.01% of ADR reports; 27.42% required hospitalization and 8.61% resulted in death. Of 6,673 ADR reports related to remdesivir, 3,928 (61.13%) patients were male. During 2020, the top three ADR reports were elevated liver function tests (17.26%), acute kidney injury (5.95%) and death (2.84%). Additionally, 42.71% of ADR reports indicated serious medical events; 19.69% resulted in death and 11.71% indicated hospitalization. The ROR and PRR of hepatic and renal events associated with remdesivir were statistically significant, (4.81 [95% CI 4.46-5.19] and 2.96 [95% CI 2.66-3.29], respectively. Conclusion: Our study showed that several serious ADRs were reported with the use of hydroxychloroquine, which resulted in hospitalization and death. Trends with the use of remdesivir were similar, but to a lesser extent. Therefore, this study showed us that off-label use should be based on thorough evidence-based evaluation.
hydroxychloroquineremdesivirCOVID-19 pandemicadverse drug reactions